Clin2
NCT06118567Possibly a fitRecruiting

Does nitrous oxide help with aggression?

Intermittent Explosive Disorder

Treatments studied

Part of Mental health clinical trials.

This study tests if a single dose of nitrous oxide (laughing gas) can reduce aggression in people with intermittent explosive disorder (IED). It compares their reactions to healthy volunteers without aggression issues.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
50 people
Ages
21 years to 55 years
Study type
Interventional

Who can take part

  • You are between 21 and 55 years old.
  • You are generally physically healthy with no serious medical conditions.
  • You can give informed consent to participate.
  • For the aggression group: You have a current diagnosis of intermittent explosive disorder (IED) and aggression scores over 12 on a standard test.
  • For the healthy group: You have no current or past psychiatric disorders and aggression scores under 12.
  • You do not have a history of psychosis, bipolar disorder, intellectual disability, or current substance abuse.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06665074Recruiting· Phase 2
Inflammation and aggression study

This trial tests how inflammation affects aggression by giving a small amount of a substance that briefly triggers your immune system. You may qualify if you have a diagnosis of Intermittent Explosive Disorder (IED), or if you are a healthy control without current anger issues.

Columbus, Ohio
NCT06118580Recruiting· Phase 2
Alcohol and aggression brain study

This study looks at how alcohol affects the brain in people with a history of aggression or alcohol use disorder. You may be able to join if you're a right-handed adult who drinks regularly and fits one of the specific groups being studied.

Columbus, Ohio
NCT05895513Recruiting· Phase 2
Pimavanserin trial for aggression and social thinking

This Phase 2 trial tests pimavanserin, a medication that may affect brain signals, to see if it can reduce aggression and improve social thinking in people with intermittent explosive disorder (IED) or a history of aggressive behavior. If you qualify, you’ll be screened with medical tests and questionnaires and must meet medication and safety rules to participate.

Columbus, Ohio
NCT07387315Not yet recruiting· Phase 4
Nitrous oxide for bladder Botox injections

This trial tests if laughing gas can ease discomfort during in-office bladder Botox injections. It's for adult women getting this treatment who may want pain relief.

Cincinnati, Ohio
NCT06636357Recruiting· Phase 2
Laughing gas for acute suicidal thoughts

This study tests whether breathing a mixture of nitrous oxide (laughing gas) and oxygen can quickly reduce strong suicidal thoughts. It's for people experiencing a mental health crisis who may need fast relief.

Zurich
NCT03826693Recruiting· Phase 2
Nitrous oxide trial for obsessive-compulsive disorder symptoms

This Phase 2 pilot study tests whether breathing nitrous oxide (laughing gas) can reduce symptoms of obsessive-compulsive disorder (OCD). It compares what happens during a treatment-free period and then during the study treatment to see if symptoms improve.

Stanford, California

Hear when a new Intermittent Explosive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.